Intellectual Property News & Topics - Secerna LLP

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more

Court Decision

European, UPC 15/03/2020

Disappointment for the Unified Patent Court in Europe

Meadowgate Gallery Four

News 01/03/2020

10 reasons to live in Yorkshire

Collaboration [Unsplash]

News 15/02/2020

Are employee inventions of outstanding benefit to your business?

Istock 1130023029

News 01/02/2020

Using design rights to protect your intellectual property

Intellectual Property

News 01/01/2020

What to expect when working with an IP attorney

New Office 2019

Team news 17/12/2019

New Office Location

B012225

Team news, Careers 01/10/2019

Jason Boakes - A day in the life of a Patent Attorney

Bio Economy

Industry news 01/09/2019

IP and the bioeconomy

Naples 2019

Events 21/08/2019

IFIB – International Forum on Industrial Biotechnology and Bioeconomy

27 28 29 30 31 32 33 34 35 36 37